The global lithotripsy devices market was valued at USD 1.25 billion in 2025 and is projected to grow steadily over the coming years, reaching USD 1.91 billion by 2034. The market is expected to expand at a CAGR of 4.87% during the forecast period (2026–2034), driven by the increasing prevalence of kidney stones, rising adoption of minimally invasive procedures, and continuous technological innovations in laser-based lithotripsy systems.

Healthcare providers worldwide are increasingly adopting advanced lithotripsy technologies to improve treatment outcomes while reducing patient recovery time and surgical complications. Growing awareness of non-invasive treatment options, expanding healthcare infrastructure, and increasing investments in urology departments are further supporting market growth.

• Market Size (2025): USD 1.25 Billion
• Market Size (2026): USD 1.31 Billion
• CAGR (2026–2034): 4.87%
• Forecast Year: 2034
• Projected Market Size (2034): USD 1.91 Billion
• Dominant Region: North America
• Fastest Growing Region: Asia-Pacific

Market Overview

Lithotripsy devices are specialized medical systems designed to fragment kidney stones and other urinary tract stones into smaller particles that can be naturally eliminated from the body. These devices utilize technologies including extracorporeal shock wave lithotripsy (ESWL), laser lithotripsy, ultrasonic lithotripsy, and intracorporeal techniques to provide safe and effective stone management.

The increasing incidence of urolithiasis across developed and emerging economies has significantly increased the demand for advanced lithotripsy systems. At the same time, hospitals and specialty urology centers continue to invest in technologically advanced devices that improve procedural precision, reduce hospitalization time, and enhance patient comfort.

Growth Drivers

One of the major factors driving the lithotripsy devices market is the growing prevalence of kidney stone disease worldwide. Changing dietary habits, sedentary lifestyles, obesity, dehydration, and aging populations have contributed to a steady increase in urolithiasis cases, creating substantial demand for efficient treatment solutions.

Another important growth driver is the strong preference for minimally invasive procedures. Compared with conventional surgery, lithotripsy offers shorter recovery periods, reduced pain, lower complication rates, smaller incisions, and shorter hospital stays. These advantages continue to encourage both healthcare providers and patients to choose lithotripsy-based treatments.

Rapid technological innovations are also contributing to market expansion. Modern laser systems, including thulium fiber lasers and advanced holmium laser technologies, provide higher precision, reduced stone migration, and improved procedural efficiency, supporting wider clinical adoption.

Market Challenges

Despite favorable growth prospects, the high acquisition and maintenance costs of lithotripsy equipment remain a major challenge for healthcare providers. The significant investment required for advanced systems can limit adoption, particularly among smaller hospitals and healthcare facilities.

In addition, lithotripsy procedures themselves can be expensive for patients in regions with limited healthcare reimbursement or inadequate insurance coverage, potentially restricting overall market growth.

Market Opportunities

Technological innovation continues to create promising opportunities across the lithotripsy devices market. The introduction of advanced laser platforms, improved imaging guidance systems, and next-generation shock wave technologies is enabling more effective stone fragmentation while minimizing patient discomfort.

Continuous product development by leading medical device manufacturers, combined with increasing regulatory approvals for innovative lithotripsy solutions, is expected to generate new growth opportunities across both developed and emerging healthcare markets.

Segment Analysis

The extracorporeal shock wave lithotripsy (ESWL) segment continues to dominate the market due to its proven clinical effectiveness, non-invasive nature, and widespread adoption in hospitals and specialty urology centers. ESWL remains one of the most preferred treatment methods for kidney stones because it minimizes surgical intervention while delivering reliable treatment outcomes.

By application, the kidney stones segment accounts for the largest share of the market. Rising incidences of renal calculi, increasing patient awareness, and growing availability of advanced treatment options continue to strengthen demand within this segment.

Among end users, hospitals remain the leading revenue-generating segment owing to their advanced infrastructure, availability of specialized urologists, higher patient volumes, and growing investments in modern medical technologies.

Regional Analysis

North America remains the largest contributor to the global lithotripsy devices market. The region benefits from advanced healthcare infrastructure, high healthcare expenditure, widespread adoption of innovative medical technologies, and the growing prevalence of kidney stone disease. Frequent product launches, regulatory approvals, and strong presence of major medical device manufacturers continue to reinforce regional market leadership.

Europe also represents a significant market driven by increasing adoption of minimally invasive procedures, expanding elderly population, and supportive regulatory approvals for advanced lithotripsy systems. Growing investments in healthcare modernization further contribute to regional expansion.

Asia-Pacific is projected to witness the fastest growth throughout the forecast period. Rapid economic development, expanding healthcare infrastructure, rising disposable incomes, increasing awareness of minimally invasive treatment options, and continuous technological advancements are driving strong market demand across countries including China, India, and Japan.

Competitive Landscape

Leading companies continue to focus on product innovation, strategic collaborations, regulatory approvals, and technological advancements to strengthen their market positions.

Key Players

• Zimmer MedizinSystems GmbH
• Olympus Corporation
• Boston Scientific Corporation
• Richard Wolf GmbH
• EDAP TMS
• NOVAMEDTEK
• Advin Health Care
• STORZ Medical AG

Recent Developments

• February 2023: Rhein Laser Technologies introduced the UroFiber 150Q SuperPulsed Thulium Fiber Laser (TFL) system for advanced stone lithotripsy treatment.
• April 2023: AVS secured an additional USD 8.8 million in Series B funding to accelerate the development of its Pulsatile Intravascular Lithotripsy (PIVL™) technology for treating calcified arterial disease.

Click to Read the Complete Insights & Report: https://straitsresearch.com/report/lithotripsy-devices-market

Future Outlook

The global lithotripsy devices market is expected to experience steady growth over the next decade as healthcare providers increasingly prioritize minimally invasive treatment options and advanced laser technologies. Rising prevalence of urinary stone diseases, continuous innovation in lithotripsy systems, expanding healthcare access in emerging economies, and favorable clinical outcomes will continue to support long-term market expansion. As manufacturers introduce more precise, efficient, and patient-friendly technologies, the market is positioned for sustained development through 2034.

About Straits Research

Straits Research is a global market intelligence and consulting company providing actionable market research, industry analysis, and business advisory services across multiple industries worldwide. The company delivers comprehensive research reports featuring in-depth market forecasts, competitive intelligence, emerging trends, growth opportunities, and strategic insights that help organizations make informed business decisions and achieve sustainable growth.